跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ISOPTIN SR verapamil hydrochloride 240mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ISOPTIN SR verapamil hydrochloride 240mg tablet blister pack
Approved
STANDARD
ISOPTIN SR verapamil hydrochloride 240mg tablet blister pack
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
353fef67899e7285
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
353fef67899e7285
Product Name
ISOPTIN SR verapamil hydrochloride 240mg tablet blister pack
Artg Id
12801
Artg Name
ISOPTIN SR 240mg verapamil hydrochloride tablet blister pack
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
1991-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/de52811a57fa5e517171993125a48d6b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f89d33b8ce7f4e57b9a67e132d4c3359.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
353fef67899e7285
Type
Standard
Back to TGA Approvals